Abiopharma

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025291 <b>Size:</b> 947 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001213900-26-094805 <b>Size:</b> 622 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025289 <b>Size:</b> 595 KB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025290 <b>Size:</b> 688 KB

(85% Positive) IBIO, INC. (IBIO) Reports Q3 2026 Financial Results

(99% Neutral) INVO FERTILITY, INC. (IVF) Files Form 8-K

(99% Positive) APREA THERAPEUTICS, INC. (APRE) Announces Enrollment Update for options Due to Patient Enrollment Issues, Regulatory Process, Safety Review

(99% Neutral) UNIFIRST CORP (UNF) Announces Executive Departure

Leifras Celebrates 25th Anniversary, Setting Vision for Becoming Global Infrastructure Through "Sports and Social"

INVO Fertility to Participate in H.C. Wainwrights 28th Annual Global Investment Conference

Special Committee of Better Home &amp; Finance Urges Shareholders to Reject Former CEO Vishal Garg’s Campaign to Seize Control of the Company

The Arena Group d/b/a Paradium.AI Completes Name Change, Will Trade Under New Stock Ticker PAAI Effective August 31, 2026

Wellchange Holdings Company Limited Announces Pricing of $7.5 Million Public Offering of its Class A Ordinary Shares

Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference

FangDD Reports First Half 2026 Unaudited Financial Results